Question 1

What are the potential benefits of participating in this trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Rectal Indomethacin vs Intravenous Ketorolac clinical trial (NCT05664074). Contact the study team or your healthcare provider for specific answers.

Question 2

How do the side effects of rectal indomethacin compare to those of intravenous ketorolac?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Rectal Indomethacin vs Intravenous Ketorolac clinical trial (NCT05664074). Contact the study team or your healthcare provider for specific answers.

Question 3

What will happen if I experience side effects during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Rectal Indomethacin vs Intravenous Ketorolac clinical trial (NCT05664074). Contact the study team or your healthcare provider for specific answers.

Question 4

How often will I need to visit the clinic if I participate?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Rectal Indomethacin vs Intravenous Ketorolac clinical trial (NCT05664074). Contact the study team or your healthcare provider for specific answers.

Question 5

What are the chances that I could receive a placebo instead of the medication?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Rectal Indomethacin vs Intravenous Ketorolac clinical trial (NCT05664074). Contact the study team or your healthcare provider for specific answers.

Question 6

Are there any other treatment options available for preventing post-ERCP pancreatitis?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Rectal Indomethacin vs Intravenous Ketorolac clinical trial (NCT05664074). Contact the study team or your healthcare provider for specific answers.

What this study is about